Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin
Open Access
- 29 May 2014
- journal article
- Published by Springer Nature in Genome Medicine
- Vol. 6 (5), 1-43
- https://doi.org/10.1186/gm559
Abstract
Background: Mucinous neoplasms of the appendix (MNA) are rare tumors which may progress from benign to malignant disease with an aggressive biological behavior. MNA is often diagnosed after metastasis to the peritoneal surfaces resulting in mucinous carcinomatosis peritonei (MCP). Genetic alterations in MNA are poorly characterized due to its low incidence, the hypo-cellularity of MCPs, and a lack of relevant pre-clinical models. As such, application of targeted therapies to this disease is limited to those developed for colorectal cancer and not based on molecular rationale. Methods: We sequenced the whole exomes of 10 MCPs of appendiceal origin to identify genome-wide somatic mutations and copy number aberrations and validated significant findings in 19 additional cases. Results: Our study demonstrates that MNA has a different molecular makeup than colorectal cancer. Most tumors have co-existing oncogenic mutations in KRAS (26/29) and GNAS (20/29) and are characterized by downstream PKA activation. High-grade tumors are GNAS wild-type (5/6), suggesting they do not progress from low-grade tumors. MNAs do share some genetic alterations with colorectal cancer including gain of 1q (5/10), Wnt, and TGFβ pathway alterations. In contrast, mutations in TP53 (1/10) and APC (0/10), common in colorectal cancer, are rare in MNA. Concurrent activation of the KRAS and GNAS mediated signaling pathways appears to be shared with pancreatic intraductal papillary mucinous neoplasm. Conclusions: MNA genome-wide mutational analysis reveals genetic alterations distinct from colorectal cancer, in support of its unique pathophysiology and suggests new targeted therapeutic opportunities.Keywords
This publication has 44 references indexed in Scilit:
- Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysisJournal of Human Genetics, 2013
- The promise of mTOR inhibitors in the treatment of colorectal cancerExpert Opinion on Investigational Drugs, 2012
- Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst DevelopmentScience Translational Medicine, 2011
- The Catalogue of Somatic Mutations in Cancer (COSMIC)Current Protocols in Human Genetics, 2008
- Aneurysm Syndromes Caused by Mutations in the TGF-β ReceptorNew England Journal of Medicine, 2006
- Appendiceal Mucinous NeoplasmsThe American Journal of Surgical Pathology, 2003
- Primary malignant neoplasms of the appendixCancer, 2002
- Sub‐family selective actions in the ability of Erk2 MAP kinase to phosphorylate and regulate the activity of PDE4 cyclic AMP‐specific phosphodiesterasesBritish Journal of Pharmacology, 2000
- Pseudomyxoma peritonei in women: A clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low malignant potentialHuman Pathology, 1995
- Inhibition by cAMP of Ras-Dependent Activation of RafScience, 1993